The National Science Foundation awarded Vena Vitals Inc. a $1 million cooperative agreement under the NSF Technology, Innovation, and Partnerships program (CFDA 47.084) to develop a wireless, continuous, non-invasive blood pressure monitoring device. The device aims to address the unmet need for real-time blood pressure monitoring of patients undergoing surgery or in critical care by capturing rapid fluctuations with high temporal resolution. Current technologies are limited in accuracy, cost...
Venarum Medical LLC received a $255,619 Project Grant award from the National Science Foundation on August 15, 2021 to support research and development activities concluding on May 31, 2022. The funding was provided through the NSF's Engineering program (CFDA #47.041), which aims to improve quality of life and economic strength through engineering innovation and excellence. Specifically, the grant supports Venarum Medical's "SBIR PHASE I: INTEGRATED MANUFACTURING OF ARTIFICIAL VALVES FOR...
Dynocardia Inc. received a $256,000 National Science Foundation Project Grant to advance development of a novel continuous, cuffless blood pressure monitoring device. Funded through the NSF Engineering Directorate's SBIR program, the award will support Dynocardia's efforts to address motion artifacts and enable accurate, beat-to-beat blood pressure measurements in hospital intensive care and operating room settings. Accurate 24-hour blood pressure monitoring has potential to significantly...
The National Heart, Lung, and Blood Institute (NHLBI) awarded Dynocardia, Inc. a $499,881 Project Grant under the Cardiovascular Diseases Research Federal Grant Program (CFDA 93.837) to complete the verification and validation (V&V) of their production-grade Vitrack hospital device. Vitrack is a wrist-wearable, cuff-less device that utilizes proprietary optomechanical sensor and computer vision technology to provide accurate, continuous, and non-invasive blood pressure monitoring. The...
This National Science Foundation (NSF) Project Grant award under CFDA Program 47.041 "Engineering" is focused on developing a novel wearable device to enable continuous, cuffless blood pressure monitoring. The goal is to create an accurate, low-cost, and easy-to-use device that can help manage hypertension and reduce hospitalizations associated with the condition. The $347,386 award to the University of Illinois supports research to establish new bioimpedance sensing methods and...
This $200,000 Project Grant awarded by the National Science Foundation (NSF) Division of Electrical, Communications and Cyber Systems under CFDA 47.041 (Engineering) aims to develop and implement a novel testing platform to evaluate the accuracy of wearable photoplethysmography-based blood pressure monitoring devices. The University of Maryland, College Park will construct a bench flow phantom that simulates physiologically relevant blood pressure, blood flow, anatomical, and optical...
This National Science Foundation (NSF) Technology, Innovation, and Partnerships (CFDA 47.084) Project Grant award provides $305,000 to Sensvita Inc. to develop a non-invasive radiofrequency sensing technology for home-based monitoring of heart and lung function. The project aims to design improved antennas for ambulatory use, enhance signal processing techniques to mitigate interference, and validate the system's accuracy against clinical benchmarks. The anticipated outcome is a robust and...
This $449,598 federal Project Grant award from the National Science Foundation's Engineering program (CFDA 47.041) aims to develop a novel wireless, noninvasive optical e-tattoo capable of continuously and simultaneously monitoring arterial and venous oxygenation. The key innovations include: (1) an ultrathin, stretchable e-tattoo with an array of photoplethysmography sensors over major artery-vein pairs; (2) algorithms to separate arterial and venous pulses and convert absorbance data into...
This National Science Foundation (NSF) Cooperative Agreement award, under the NSF Technology, Innovation, and Partnerships (CFDA 47.084) program, provides $999,553 to Dynocardia, Inc. to develop advanced computer vision and artificial intelligence algorithms for motion artifact correction in their Vitrack wearable blood pressure monitoring device. The project aims to enable accurate, continuous blood pressure measurements across various clinical settings, including hospitals, where patient...
This National Science Foundation (NSF) Project Grant award under CFDA 47.041 (Engineering) supports the development of a new computational model to predict the complex interactions between ventricular assist devices (VADs) and the beating native heart. The goal is to create a "digital twin" of an experimental mock circulatory loop used for testing VAD safety and efficacy. This $195,291 award, effective August 1, 2024 through July 31, 2026, will result in a lumped parameter model that...